all-trans-retinol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×10“Vitamin A was associated with a 24% reduction in all cause mortality (0.76, 95% confidence interval 0.69 to 0.83; fig 3), though there was moderate heterogeneity (χ2=29.10, df=15, P=0.02; I2=48%).”
Quoted verbatim from Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis.. - Study
- meta-analysis
- Dose
- synthetic oral vitamin A, mostly 100,000 IU (<12 months) or 200,000 IU (older) every 4 to 6 months, some single dose or weekly
- Population
- Apparently healthy children aged 6 months to 5 years in 16 randomised trials of prophylactic synthetic oral vitamin A versus placebo or no treatment; all-cause mortality at longest follow-up (mostly about one year)
Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis.2011PMID:21868478An author is affiliated with a producerPermalink
Keep reading
- Everything the graph holds on all-trans-retinol
- Every compound studied against All-cause mortality
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5JRB0KWHW25MZY7X60PNT5F